» Articles » PMID: 2555181

Isolation of CDNA Clones Encoding Human Acid Sphingomyelinase: Occurrence of Alternatively Processed Transcripts

Overview
Journal EMBO J
Date 1989 Sep 1
PMID 2555181
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Acid sphingomyelinase (sphingomyelin phosphodiesterase, EC 3.1.4.12) was purified from human urine and 12 tryptic peptides were microsequenced (128 residues). Based on regions of minimal codon redundancy, four oligonucleotide mixtures were synthesized and oligonucleotide mixture 1 (20mer; 256 mix) was used to screen 3 X 10(6) independent recombinants from a human fibroblast cDNA library. Putative positive clones (92) were purified and analyzed by Southern hybridization with oligonucleotide mixtures 2-4. These studies revealed two groups of clones; group 1 (80 clones; inserts ranging from approximately 1.2 to 1.6 kb) hybridized with oligonucleotides mixtures 1-4, while group II (12 clones; inserts ranging from approximately 1.2 to 1.4 kb) hybridized with oligonucleotide mixtures 1-3. Several group II clones had larger inserts than those in group I, but did not hybridize with oligonucleotide mixture 4. Screening of a human placental cDNA library with a 450 bp group I fragment, also resulted in the isolation of group I and II clones. Representative clones from group I (pASM-1) and group II (pASM-2) were sequenced. pASM-1 contained a 1879 bp insert which was colinear with 96 microsequenced amino acids, while the pASM-2 1382 bp insert was colinear with 78 microsequenced residues. Notably, pASM-2 did not have an internal 172 bp sequence encoding 57 amino acid residues, but had instead an in-frame 40 bp sequence encoding 13 amino acids which was not present in pASM-1. These findings demonstrate the presence of two distinct acid sphingomyelinase transcripts in human fibroblasts and placenta and suggest the occurrence of alternative processing of the mRNA encoding this lysosomal hydrolase.

Citing Articles

Sphingosine Prevents Rhinoviral Infections.

Lang J, Soddemann M, Edwards M, Wilson G, Lang K, Gulbins E Int J Mol Sci. 2024; 25(5).

PMID: 38473734 PMC: 10931046. DOI: 10.3390/ijms25052486.


Consensus clinical management guidelines for acid sphingomyelinase deficiency (Niemann-Pick disease types A, B and A/B).

Geberhiwot T, Wasserstein M, Wanninayake S, Bolton S, Dardis A, Lehman A Orphanet J Rare Dis. 2023; 18(1):85.

PMID: 37069638 PMC: 10108815. DOI: 10.1186/s13023-023-02686-6.


Diverse Roles of Ceramide in the Progression and Pathogenesis of Alzheimer's Disease.

Chowdhury M, Jin H, Bae J Biomedicines. 2022; 10(8).

PMID: 36009503 PMC: 9406151. DOI: 10.3390/biomedicines10081956.


IgG Fusion Proteins for Brain Delivery of Biologics via Blood-Brain Barrier Receptor-Mediated Transport.

Boado R Pharmaceutics. 2022; 14(7).

PMID: 35890374 PMC: 9322584. DOI: 10.3390/pharmaceutics14071476.


Acid Sphingomyelinase, a Lysosomal and Secretory Phospholipase C, Is Key for Cellular Phospholipid Catabolism.

Breiden B, Sandhoff K Int J Mol Sci. 2021; 22(16).

PMID: 34445706 PMC: 8396676. DOI: 10.3390/ijms22169001.


References
1.
Caruthers M . Gene synthesis machines: DNA chemistry and its uses. Science. 1985; 230(4723):281-5. DOI: 10.1126/science.3863253. View

2.
Levade T, Salvayre R, DOUSTE-BLAZY L . Sphingomyelinases and Niemann-Pick disease. J Clin Chem Clin Biochem. 1986; 24(4):205-20. View

3.
Stone K, Williams K . High-performance liquid chromatographic peptide mapping and amino acid analysis in the sub-nanomole range. J Chromatogr. 1986; 359:203-12. DOI: 10.1016/0021-9673(86)80074-7. View

4.
Oshima A, KYLE J, Miller R, Hoffmann J, Powell P, Grubb J . Cloning, sequencing, and expression of cDNA for human beta-glucuronidase. Proc Natl Acad Sci U S A. 1987; 84(3):685-9. PMC: 304280. DOI: 10.1073/pnas.84.3.685. View

5.
Quintern L, Weitz G, Nehrkorn H, Tager J, Schram A, Sandhoff K . Acid sphingomyelinase from human urine: purification and characterization. Biochim Biophys Acta. 1987; 922(3):323-36. DOI: 10.1016/0005-2760(87)90055-5. View